Skip to content

Life Sciences

EU GMP Chapter 8: has the recall procedure ever been tried?

  • Life Sciences
  • 1 min read

A recall procedure that has never been tried is an assumption with a document number.

EU GMP Chapter 8 covers complaints, quality defects and recalls, and most of what it says can be tested.

On complaints, it says appropriately trained and experienced personnel should be responsible for managing complaint and quality defect investigations, independent of the sales and marketing organization unless otherwise justified. If a quality defect is discovered or suspected in a batch, consideration should be given to checking other batches, and in some cases other products.

The recall clauses are more specific. Recall operations should be capable of being initiated promptly and at any time. Distribution records should be readily available to the persons responsible for recalls, with customer contact details inside and outside working hours. The effectiveness of the recall arrangements should be periodically evaluated too, for office hours and out of hours, with the evaluation documented and justified.

The chapter stops short of saying a mock recall has to be run. It says consideration should be given as to whether one should be performed.

A fair evaluation can be small. Take one shipped batch on a Saturday evening, ask the on-call person for its distribution list, and ring the out-of-hours numbers of the first three customers on it. Time the whole thing. The numbers that no longer answer are the finding.

Topics

Industries

Related

More on this subject

From EU importer to EudraGMDP: the certificate route

A plant outside the EU earns an EU GMP certificate after an inspection by an EEA competent authority, usually triggered by the EU importer or MAH. Site Master File, inspection, graded deficiencies and a CAPA response come first; the certificate, or a non-compliance statement, then appears in EudraGMDP.

InsightRead

A Vietnamese manufacturer can reach the EU market by acquiring a marketing authorisation and transferring the site, by new registration via technology transfer, or by in-house development. All three need an EU GMP site and quality system, an EU-based MAH, a Qualified Person and pharmacovigilance.

InsightRead

Functional specification: the document OQ tests against

A URS line such as 'alarm on low room pressure' cannot be tested as written. The functional specification says how the system will behave, function by function. In the usual V-model it faces OQ, so it should be numbered and approved before configuration starts, not reconstructed by the tester from the running system.

InsightRead